Morningstar

Tandem Diabetes Care Inc TNDM

Morningstar Rating
Unlock
Stock XNAS Rating as of
$15.80 −0.43 (2.65%)
View Full Chart
As of Delayed Price Closed

Company Report

View Archive

Price vs Fair Value

View History
TNDM is trading at a 827% premium.
Price
$16.22
Fair Value
$41.00
Uncertainty
Gdgh Yryd
1-Star Price
$25.00
5-Star Price
$19.00
Economic Moat
Lss
Capital Allocation
Zxnpyqfl

Bulls Say, Bears Say

Bulls

Tandem’s t:slim X2 features a low-profile, color touchscreen that is very user-friendly for patients new to insulin pumps.

Bears

Medtronic arguably enjoys more accurate and advanced algorithms thanks to its far larger patient user base and proprietary data—a major reason why it remains a step ahead of Tandem in closing the loop.

Show More

News

View All

Articles & Videos

Trading Information

Previous Close Price
$16.23
Day Range
$15.38–16.06
52-Week Range
$9.98–29.65
Bid/Ask
$15.80 / $16.46
Shares Outstanding
68.53M
Market Cap
$1.08B
Volume/Avg
4M / 2M

Key Statistics

Price/Earnings (Normalized)
258.81
Price/Sales
1.16
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield
—

Company Profile

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
2,500
Website
https://www.tandemdiabetes.com

Competitors

Valuation

View More
Metric
TNDM
PODD
DXCM
Price/Earnings (Normalized)
 258.8129.6733.54
Price/Book Value
 9.118.4910.20
Price/Sales
 1.163.906.52
Price/Cash Flow
 36.0018.5621.46
Price/Earnings
TNDM
PODD
DXCM

Financial Strength

Metric
TNDM
PODD
DXCM
Quick Ratio
 2.871.491.58
Current Ratio
 3.582.491.95
Interest Coverage
 −15.636.7966.86
Quick Ratio
TNDM
PODD
DXCM

Profitability

Metric
TNDM
PODD
DXCM
Return on Assets (Normalized)
 0.46%11.75%13.27%
Return on Equity (Normalized)
 3.02%27.21%34.54%
Return on Invested Capital (Normalized)
 0.26%15.65%17.86%
Return on Assets
TNDM
PODD
DXCM

Medical Devices Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
BpqnmmntNmgcpq$159B
 Stryker Corp
SYK
XftypwwdQjgg$120B
 Medtronic PLC
MDT
TzvkqxwqmRrnbhy$103B
 Boston Scientific Corp
BSX
LbrhqmlRwpmsxv$72B
 Edwards Lifesciences Corp
EW
XwhcvlvfwJfsjjq$50B
 GE HealthCare Technologies Inc Common Stock
GEHC
QslcszzBymtp$29B
 DexCom Inc
DXCM
RywlkwnnscPmwnwv$29B
 Koninklijke Philips NV ADR
PHG
JyhhwChxj$26B
 Steris PLC
STE
CbmldsfBqqlmlv$20B
 Zimmer Biomet Holdings Inc
ZBH
XbvhgvvjChgkk$17B

Sponsor Center